Open Access

Effects of Er-Miao-San extracts on TNF-alpha-induced MMP-1 expression in human dermal fibroblasts

Biological Research201548:8

https://doi.org/10.1186/0717-6287-48-8

Received: 22 September 2014

Accepted: 8 January 2015

Published: 26 January 2015

Abstract

Background

Various health benefits have been attributed to Er-Miao-San (EMS), a traditional Chinese herbal formulation that contains equal amounts of cortex phellodendri (Phellodendron amurense Ruprecht) and rhizoma atractylodis (Atractylodes lancea D.C). However, its effect on the anti-inflammatory activity in human dermal fibroblasts (HDFs) and the mechanism underlying this effect are unknown.

Results

This study investigated the effects of EMS on TNF-α-induced MMP-1 expression in HDFs. Our data show that EMS inhibited TNF-α-induced MMP-1 expression in a concentration-dependent manner. Interestingly, EMS maintained IκB content without inhibiting the phosphorylation of MAPKs, which are well-established upstream kinases of NF-κB. Moreover, EMS reduced the level of nuclear p65 protein in HDFs. Luciferase assay revealed that EMS inhibits the transcriptional activity of NF-κB by stabilizing IκB. Our results show that EMS exerts its anti-inflammatory effect by inhibiting NF-κB-regulated genes such as IL-1β and IL-8. Moreover, EMS effectively inhibited TNF-α-induced expression of MMP-1 via the NF-κB pathway.

Conclusions

Taken together, our data suggest that EMS could potentially be used as an anti-inflammatory and anti-aging treatment.

Keywords

Er-Miao-San MMP1 Human dermal fibroblasts TNF-α NF-κB

Background

Skin aging can be divided into two types, namely intrinsic aging, which is caused by the natural consequences of physical change, and extrinsic aging, which is caused by exposure to environmental factors such as ultraviolet (UV) rays and pollutions [1]. Oxidative stress due to UVB, an extrinsic aging factor, causes DNA damage, and leads to human dermal fibroblast (HDF) senescence [2]. In addition, inflammation of skin cells caused by various environmental factors is also known to be a representative factor that induces skin aging [3].

Wrinkle formation is the most representative characteristic of skin aging, and is closely related to a reduction in skin elasticity and degeneration of the extracellular matrix (ECM) [4]. The ECM consists of a mesh of fibrous proteins, such as collagen, elastic fibers, and glycosaminoglycans, which are generated by fibroblasts. These cells synthesize procollagen type-1 (Col-1) and type-3 (Col-3) in the dermis and secrete matrix metalloproteinase (MMP), an enzyme that degrades nearly all ECM components, including collagen. Wrinkle formation is caused by the secretion of higher levels of MMP-1 and reduction of procollagen synthesis in HDFs [5]. Several compounds including cordycepin and brazilin have recently been suggested as possible anti-aging agents through suppressing the secretion of MMP-1 and MMP-3 in HDFs [6, 7].

NF-κB is one of transcription factors and forms homo-and heterodimer complexes with Rel family proteins such as RelA (p65), RelB, cRel, p50, and p52 [8]. The transcriptional activity of NF-κB is mainly regulated by its intracellular localization, which is primarily controlled by inhibitor of κB (IκB) [8]. IκB can dimer with NF-κB, which induces cytoplasmic retention of NF-κB [9]. Upon lipopolysaccharide (LPS) or cytokine stimulation, IκB kinase (IKK) is activated and phosphorylates IκB, and then phosphorylated IκB underwent polyubiquitination-mediated proteasomal degradation [10]. Following the degradation of IκB, NF-κB translocates to the nucleus and induces transcription of various inflammatory genes, including interleukin (IL)-1β and IL-8 [11, 12]. Accumulating studies have also shown that NF-κB regulates skin aging by regulating the expression level of MMP-1 in dermal fibroblasts [13, 14]. Interestingly, it was reported that suppression of NF-κB activation reduces MMP-1 expression in HDFs and inhibits skin photoaging [15]. Furthermore, inflammation-induced activation of NF-κB causes deterioration of dermal tissue by promoting the expression of MMP-1, which exerts degradation of dermal type I collagen [16].

Er-Miao-San (EMS) is a compound commonly found in traditional Chinese medicine (TCM) that consists of equal amounts of Cortex Phellodendri (CP) and Rhizoma Atractylodis (RA). The major component of CP, berberine, promotes the apoptosis of cancer cells by regulating caspase-3 [17]. In 3 T3-L1 adipose cells, free fatty acid-induced insulin resistance was recovered by berberine through activation of inhibitor of κB kinase-β (IKK-β) [18]. Moreover, berberine prevents receptor activator of nuclear factor kappa-B ligand (RANKL)-induced NF-κB activation by blocking phosphorylation of inhibitor of κBα (IκBα) [19]. RA extract has been known to inhibit the activity of cyclooxygenase-1 (COX-1) [20], 15-lipoxygenase [21], and thromboxane [22], as well as block the expression of interleukin (IL)-1β/IL-6 [23] and IL-2 [24]. Studies have shown that RA also inhibits NF-κB [25], and that EMS exerts beneficial effects on prevention of cancer progression, inflammation, atherosclerosis, and arthritis [26, 27]. However, little is known about the biological effects of EMS on skin aging.

TNF-alpha (TNF-α) is one of the major inflammatory cytokines [28]. It was reported that TNF-α induces MMP1 expression and suppresses collagen synthesis in HDFs [28]. After TNF-α stimulation in cells, NF-κB is activated and acted as a transcription factor for MMP1 expression [8, 13]. Besides IκB, mitogen-activated protein kinases (MAPKs) are important signaling molecules that affect NF-κB activation [29], as evidenced by the lack of NF-κB transactivation following MAPK inhibition [29]. Here, we demonstrated that treatment with EMS inhibits TNF-α-induced MMP-1 expression through suppressing NF-κB nuclear localization in HDFs. Also, we observed that EMS-mediated NF-κB inhibition was not dependent on MAPK signaling pathways in HDFs.

Results

Effect of EMS on cell viability

We first investigated whether the treatments of EMS, CP and RA on human skin dermal fibroblasts will induce cytotoxic or non-cytotoxic properties, and what are the non-cytotoxic concentration ranges of EMS, CP and RA on human skin dermal fibroblasts before further experiments that investigate the EMS-induced protection effect on TNF-α-induced MMP-1 expression. Therefore, we set the experimental conditions as followed; the treatment concentrations is 0 – 1000 μg/ml, and the treatment time is 24 h. To examine the cytotoxicity of EMS, CP, and RA, HDFs were treated with various concentrations (0–1000 μg/ml) of the reagents for 24 h, and the WST-1 assay was performed to evaluate cell viability. As shown in Figure 1A and C, treatment with EMS and RA slightly increased the cell viability of HDFs as the concentration increased. Interestingly, treatment with less than 500 μg/ml CP did not induce any significant cytotoxicity relative to the control; however, the viability was decreased to 75.1% when HDF cells were treated with 1000 μg/ml CP, respectively (Figure 1B). Therefore, we concluded that although larger dose of CP (1000 μg/ml) show cytotoxicity in HDFs, EMS, which contain equal amount of CP and RA, is not cytotoxic reagent in HDFs, and the doses of 250 and 500 μg/ml EMS, CP and RA were used in further experiments.
Figure 1

The effect of EMS on cell viability in HDFs. Cell viability was determined by the WST-1 assay. HDFs were incubated with 62.5-1000 μg/ml EMS (A), Cortex Phellodendri (CP) (B), or Rhizoma Atractylodis (RA) (C) for 24 h. The graph represents mean ± S.D. of relative cell viability from three independent experiments.

Effect of EMS on TNF-α-induced expression of MMP-1mRNA

We next investigated whether TNF-α-induced downregulation of MMP1 expression could be regulated by treating EMS in HDFs. HDFs were seeded and pretreated with 250 and 500 μg/ml EMS for 3 h, and then exposed to TNF-α for 4 h. After TNF-α stimulation, cells were gathered and the expression level of MMP1 was investigated using RT-PCR with its specific primers. As shown in Figure 2A, TNF-α increased the expression level of MMP1 by 6.75 ± 0.81 fold compared with non-treated control cells. However, 250 and 500 μg/ml EMS treatments before TNF-α stimulation significantly inhibited the expression level of MMP1 by 4.26 ± 0.37 and 2.26 ± 0.21 fold, respectively, as compared with non-treated control cells (Figure 2A). Of note, the upregulated MMP1 expression induced by TNF-α was largely downregulated to 33.57% in 1000 μg/ml EMS pretreated HDFs as compared with TNF-α treated cells. Furthermore, we investigated which component between CP and RA could regulate the TNF-α-induced MMP1 expression. HDFs were seeded and pretreated with 250 μg/ml CP and RA for 3 h, and then exposed to TNF-α for 4 h. As shown in Figure 2B, both CP and RA pretreatments significantly inhibited the TNF-α-induced MMP1 upregulation in HDFs. Overall, we conclude that EMS pretreatment significantly inhibits TNF-α-induced MMP1 expression in HDFs.
Figure 2

The effect of EMS on TNF-α-induced MMP-1 mRNA expression in HDFs. HDFs were pre-treated with 250–500 μg/ml EMS (A), 250 μg/ml CP and 250 μg/ml RA for 3 h (B), and subsequently stimulated with 10 ng/ml TNF-α for 4 h. The level of MMP-1 mRNA was determined by qRT-PCR. Independent experiments were performed in triplicate (*p < 0.05).

Effect of EMS on IκB degradation and NF-κB transactivation activity

We investigated whether EMS-mediated inhibition of TNF-α-induced MMP1 expression is associated with NF-κB activity in HDFs. First, we confirmed that TNF-α stimulation decreased the protein level of IκB in HDFs (Figure 3A, lane 1 and 3). Next, to investigate the effect of EMS on TNF-α-induced IκB degradation, HDFs were seeded and pretreated with 250 and 500 μg/ml EMS before TNF-α stimulation. As shown Figure 3A, pretreatment with EMS rescued the decreased IκB protein mediated by TNF-α stimulation in HDFs. Third, we also found that the total and nuclear protein level of p65, which is subunit of NF-κB [8], was increased by TNF-α stimulation and the increased p65 protein was largely decreased by EMS pretreated HDFs, indicating that TNF-α-induced NF-κB nuclear translocation was inhibited by EMS treatment in HDFs (Figure 3A). Lastly, we further examined whether EMS-mediated inhibition of TNF-α-induced p65 nuclear translocation is indeed related with transcriptional activity of NF-κB in HDFs. Using NF-κB luciferase reporter NIH-3 T3 fibroblasts, we investigated the NF-κB activity after EMS and TNF-α treatment. As shown in Figure 3B, pretreatment with EMS significantly decreased the upregulated luciferase activity mediated by TNF-α, indicating that EMS inhibits TNF-α-induced NF-κB activation. Notably, TNF-α only stimulation increased the luciferase activity to 3.21 ± 0.31 compared with non-treated control cells; however, EMS pretreatment before TNF-α stimulation increased the luciferase activity only to 2.16 ± 0.07 and 1.23 ± 0.19 fold compared with non-treated control, respectively (Figure 3B). Therefore, we conclude that EMS inhibits TNF-α-induced NF-κB activation and MMP1 expression in HDFs.
Figure 3

The effect of EMS on IκB degradation and NF-κB transactivation in TNF-α-induced HDFs. HDFs were pre-treated with 250–500 μg/mL EMS for 3 h, and subsequently stimulated with 10 ng/mL TNF-α for 4 h. (A) IκB and p65 protein levels were analyzed by western blot. Nuclear p65 protein was analyzed using nuclear extracts. Lamin B was used as the loading control. The relative expression ratio of each band was calculated after densitometric analysis using image J software and normalization to β-actin or Lamin B signal. *p < 0.05 compared with control or TNF-α-treated group. (B) NF-κB transactivation activity was determined by luciferase assay using NF-κB reporter NIH-3 T3 cells. (C) The level of IL-1β mRNA was determined by real-time qPCR. (D) The level of IL-8 mRNA expression was determined by real-time qPCR. Independent experiments were performed in triplicate (*p < 0.05).

NF-κB activates transcription of IL-1β and IL-8 by binding to their promoters [11, 12], leading to inflammation and degradation of the tissue matrix structure by inducing the formation of inflammatory mediators such as COX-2, PGE2, and MMP [30]. Thus, we performed qRT-PCR to examine the effect of EMS on IL-1β and IL-8 expression. Our results indicate that the level of IL-1β and IL-8 mRNA increased following TNF-α treatment, but was decreased by EMS in a dose-dependent manner (Figure 3C and D).

Effects of EMS on phosphorylation of MAPK pathway

To investigate the effect of EMS on the MAPK pathway, ERK, JNK, and p-38 phosphorylation were investigated after treatment with EMS and TNF-α in HDFs. Immunoblotting results showed that pretreatment with EMS did not altered the TNF-α-induced phosphorylation of ERK, JNK, and p-38 in HDFs (Figure 4). Therefore, these results showed that the intracellular mechanism of EMS-mediated inhibition of TNF-α-induced NF-κB activation and MMP-1 expression is independent of the MAPK signaling cascade in HDFs.
Figure 4

The effect of EMS on phosphorylation of MAPK in TNF-α-induced HDFs. The phosphorylation of ERK, p38, and JNK was analyzed by western blot analysis. As controls, cells were treated with 10 μM PD98059 (an ERK inhibitor) (A), SB203580 (a p38 inhibitor) (B), or SP600125 (a JNK inhibitor) (C). (D) The relative expression ratio of each p-ERK, p-p38 and p-JNK was calculated after densitometric analysis using image J software and normalization to each ERK, p38 and JNK signal. *p < 0.05 compared with non-treated control group.

Discussion

Skin is constantly in direct contact with the environment, thereby inducing aging and skin damage [1]. Wrinkle formation, the most representative characteristic of skin aging, is caused by oxidative stress and inflammation of skin cells. Thus, compounds that exhibit an anti-inflammatory effect on skin cells have been suggested as promising anti-aging agents [6, 7]. In this study, we investigated the inhibitory effect of EMS on inflammation-induced skin aging. Therefore, examination of the effect of EMS on TNF-α-induced MMP-1 expression in HDFs indicated that pre-treatment with EMS for 3 h decreased MMP-1 mRNA in a concentration-dependent manner (Figure 2A). CP and RA treatment also decreased the expression level of MMP-1 mRNA (Figure 2B), suggesting that these active ingredients might synergistically inhibit TNF-α-induced MMP-1 expression.

The expression of MMP-1 in response to inflammation is regulated by the transcription factor NF-κB. In HDFs, NF-κB activation is involved in regulating inflammation through various intracellular signaling pathways, including the MAPK pathway [30]. MAPKs constitute a group of serine/threonine protein kinases that can be subdivided into three subfamilies: p42/p44 ERK, JNK, and p38 MAPK. MAPKs are activated by various extracellular stimuli and induce the phosphorylation of key signaling molecules associated with cell proliferation, inflammation, and apoptosis [31]. As shown in Figure 4A, B and C, we found that EMS inhibited TNF-α-induced activation of NF-κB. Also, we found that EMS inhibited TNF-α-induced MMP-1 expression. The phosphorylation of MAPKs, which is one of NF-κB activators, was also known to be regulated by TNF-α stimulation [29]. However, we found that the increased levels of phosphorylation of MAPKs by TNF-α stimulation were not changed in EMS-treated cells. Those results indicated that EMS-dependent MMP-1 expression is not related with the phosphorylation of MAPKs, and EMS-dependent NF-κB activation would not be dependent on the phosphorylation level of MAPKs. Therefore our results suggest that EMS inhibits the NF-κB pathway independent of the MAPK pathway.

Association of IκB with the NF-κB p65/p50 dimer plays an important role in regulating the nuclear translocation and target gene transcription by NF-κB. It is well established that IκB degradation induces the nuclear translocation of p65 [8]. Thus, we assessed the level of IκB in TNF-α-stimulated HDFs following EMS treatment. Our data show that EMS treatment increased the level of IκB and decreased nuclear p65 (Figure 3A). Nuclear translocation of NF-κB due to IκB degradation is essential for activating NF-κB [8]. We further explored this situation by assessing NF-κB transactivation activity. NF-κB transactivation was found to be increased by TNF-α treatment, but significantly decreased by EMS in a concentration-dependent manner (Figure 4B). In addition, EMS inhibited the expression of IL-1β and IL-8, which are regulated by NF-κB (Figure 4C,D). In conclusion, our results demonstrate that EMS exerts its anti-inflammatory effect on skin by inhibiting the TNF-α-induced expression of MMP-1 in HDFs by blocking NF-κB. EMS reduces inflammation by increasing the level of IκB present in the cell, which reduces p65 nuclear translocation and thus NF-κB transactivation. Also, several reports have showed that inhibition of NF-κB activation suppresses MMP-1 expression in several cells including human dermal fibroblasts [32, 33]. Our data showed that EMS-dependent loss of MMP-1 expression was mediated by EMS-mediated inhibitory effect on NF-κB activation. Therefore, our results also suggest that the effect of EMS-dependent loss of MMP1 expression might be strengthened by treatment with NF-κB inhibitors.

Conclusions

In summary, we examined the inhibitory effect of EMS on inflammation-induced NF-κB activation and MMP1 generation in HDFs. Our data suggest that EMS is a potential anti-aging agent against inflammation-induced skin aging.

Methods

Herbal extraction and characterization

Dried CP and RA were obtained from the oriental pharmacy in Kyung Hee Hospital of Oriental Medicine, Kyung Hee University (Seoul, Korea). The each dried sample (20 g) was added to 200 ml sterilized distilled water (DW) to produce a 10% solution. For EMS, equal amounts (10 g) of the dried CP and RA were added to 200 ml sterilized DW to be 10% solution. Those solutions were subsequently extracted for 24 h at 60°C and then filtered. After the extraction and filtration, the extracts were subjected to vacuum evaporating and freeze-drying. Finally, we obtained 3.043 g of EMS, 2.548 g of CP, and 2.997 g of RA, respectively. These powders were dissolved into the tissue cell culture medium and used for experiments.

Cell culture and treatment

HDFs were obtained from Lonza (Basel, Switzerland) and cultured in Dulbecco's Modified Eagle Medium (DMEM; WELGENE Inc., Daegu, Korea) supplemented with 10% fetal bovine serum, 100 U/ml of penicillin, and 100 μg/ml of streptomycin. The cells were maintained at 37°C in a 5% CO2 incubator. TNF-α was purchased from Sigma-Aldrich (St. Louis, Mo, USA). Cells (1 × 106 or 3 × 105) were seeded in 60 pi or 6-well cell culture dishes and incubated for overnight. After incubation, the cells were treated with 10 ng/ml TNF-α for 4 h in a serum-free media. All experiments handling human cells were carried out in line with the Tenets of the Declaration of Helsinki.

Quantitative real-time PCR analysis

cDNAs were synthesized from total RNA using M-MLV reverse transcriptase (Enzynomics, Seoul, Korea) according to the manufacturer’s protocol. The forward and reverse primers for human MMP-1 were 5′-TCTGACGTTGATCCCAGAGAGCAG-3′ and 5′-CAGGGTGACACCAGTGACTGCAC-3′, respectively. The forward and reverse primers for human β-actin were 5′-GGATTCCTATGTGGGCGACGA-3′ and 5′-CGCTCGGTGAGGATCTTCATG-3′, respectively. The forward and reverse primers for human IL-1β were 5′-ACAGATGAAGTGCTCCTTCCA-3′ and 5′-GTCGGAGATTCGTAGCTGGAT-3′, respectively. Also the forward and reverse primers for human IL-8 were 5′-ATGACTTCCAAGCTGGCCGTGGCT-3′ and 5′- TCTCAGCCCTCTTCAAAAACTTCTC-3′, respectively. PCR was performed using the HOT FIREPol EvaGreen PCR Mix Plus (Solis BioDyne, Estonia) with Line gene K software (Bioer Technology Co., Ltd., Hangzhou, China). The CT-value for MMP-1, IL-1β and IL-8 were normalized to β-actin. The 2-ΔΔCt method was used to calculate relative expression level of MMP-1, IL-1β and IL-8. Data were presented as mean ± S.D. (n = 9; three independent experiments).

Cell viability assay

Cell viability was assessed using the WST-1 assay according to the manufacturer’s instructions (Itsbio, Seoul, Korea). The results are represented graphically as the measured cell viability ratio normalized to the control.

Western blotting

Cellular proteins was extracted by lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.1% SDS, and 0.5% sodium deoxycholate) and EDTA-free protease and phosphatase inhibitor cocktail (Roche, Switzerland). Equal amounts of protein samples were separated by 10% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis and then transferred onto nitrocellulose membrane (Whatman Protan BA83, GE Healthcare Life Science, Freiburg, Germany). After blocking with 5% skim milk for 1 h at room temperature, the membranes were incubated first with primary antibody at 4°C overnight and subsequently with peroxidase-conjugated secondary antibody at room temperature for 1 h. The protein bands were detected using enhanced chemiluminescence reagents. Primary antibody specific for MMP1 NF-κB-p65, IκB and Lamin B were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-β-actin antibody was purchased from Sigma-Aldrich (St. Louis, MO, USA). Anti-p38, p38, pERK, ERK, pJNK and JNK were purchased from Cell Signaling Technology (Danvers, MA, USA).

Preparation of nuclear protein extracts

Cells were gently resuspended in 500 μl of buffer A (10 mM HEPES, pH 7.5, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, and 0.05% NP-40) and then incubated for 20 min on ice. The cells were centrifuged for 5 min at 3,000 × g at 4°C. Then, 25 μl of buffer B (1% Triton X-100, 300 mM NaCl, 5 mM HEPES, pH 7.5, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, and 26% glycerol) was added, and the samples were mixed prior to centrifugation for 20 min at 12,000 × g at 4°C. The supernatant (nuclear protein extract) was collected and stored at -80°C until use.

NF-κB transactivation activity assay

NF-κB-luciferase reporter stable NIH-3 T3 cell line, which was stably transfected with the NF-κB-luciferase reporter vector (pNF-κB-luc; Affymatrix-Panomics, Santa Clara, CA, USA), was purchased from Affymatrix-Panomics. pNF-κB-luc was designed to measure the transcriptional activity of NF-κB. Six copies of NF-κB binding sequences (5′-GGGAATTTCCGGGAATTTCCGGGAATTTCCGGGAATTTCCGGGAATTTCCGGGAATTTCC-3′) were subcloned into the upstream region of luciferase cDNA. The NIH-3 T3/NF-κB-luc cell line was obtained by co-transfection of pNF-κB-luc (Affymatrix-Panomics) and pHyg into NIH-3 T3 cells, followed by hygromycin selection. To test NF-κB activity, approximately 1 × 105 NF-κB reporter NIH-3 T3 stable cells were seeded onto 60-mm culture dishes and cultured for 24 h. Cells were then lysed by adding Passive Lysis Buffer (Promega, Madison, WI, USA) and incubating for 30 min on ice. After centrifugation for 30 min at 12,000 × g at 4°C, the supernatant was collected. The cell lysate was treated with luciferin (Promega) and its luminescence was measured using a Veritas Luminometer (Turner Designs, Sunnyvale, CA, USA). Results shown are the averages of three independent experiments.

Statistical analysis

A result of three observations per group was subjected to a statistical analysis. Data are presented as mean ± the standard deviation (S.D.). Statistical analysis was performed using two-tailed Student’s t-test analysis. P < 0.05 was considered significant.

Declarations

Acknowledgements

This paper was supported by the KU Research Professor Program of Konkuk University and a grant from the Korean Health Technology R&D Project (Grant No. HN13C0080), Ministry of Health & Welfare, Republic of Korea.

Authors’ Affiliations

(1)
Korea Institute for Skin and Clinical Sciences and Molecular-Targeted Drug Research Center, Konkuk University
(2)
Department of Bioengineering, Graduate School of Konkuk University
(3)
Department of Beauty Education, Graduate School of Education, Konkuk University

References

  1. Farage MA, Miller KW, Elsner P, Maibach HI: Intrinsic and extrinsic factors in skin ageing. Int J Cosmetic 2008, 30:87–95. 10.1111/j.1468-2494.2007.00415.xView ArticleGoogle Scholar
  2. Li Y, Bi Z, Yan B, Wan Y: UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway. Int J Mol Med 2006, 18:713–9.PubMedGoogle Scholar
  3. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y: Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002, 138:1462–70.PubMedGoogle Scholar
  4. Egbert M, Ruetze M, Sattler M, Wenck H, Gallinat S: The matricellular protein periostin contributes to proper collagen function and is downregulated during skin aging. J Dermatol Sci 2014, 73:40–8. 10.1016/j.jdermsci.2013.08.010View ArticlePubMedGoogle Scholar
  5. Talwar HS, Griffiths CE, Fisher GJ, Hamilton TA, Voorhees JJ: Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol 1995, 105:285–90. 10.1111/1523-1747.ep12318471View ArticlePubMedGoogle Scholar
  6. Lee YR, Noh EM, Jeong EY, Yun SK, Jeong YJ, Kim JH, et al.: Cordycepin inhibits UVB-induced matrixmetalloproteinase expression by suppressing the NF-kappaB pathway in human dermal fibroblasts. Exp Mol Med 2009, 41:548–54. 10.3858/emm.2009.41.8.060View ArticlePubMed CentralPubMedGoogle Scholar
  7. Lee YR, Noh EM, Han JH, Kim JM, Hwang JK, Hwang BM, et al.: Brazilin inhibits UVB-induced MMP-1/3expressions and secretions by suppressing the NF-kappaB pathway in human dermal fibroblasts. Eur J Pharmacol 2012, 674:80–6. 10.1016/j.ejphar.2011.10.016View ArticlePubMedGoogle Scholar
  8. Bharti AC, Aggarwal BB: Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002, 64:883–8. 10.1016/S0006-2952(02)01154-1View ArticlePubMedGoogle Scholar
  9. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS Jr: I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev 1992, 6:1899–913. 10.1101/gad.6.10.1899View ArticlePubMedGoogle Scholar
  10. Pennington KN, Taylor JA, Bren GD, Paya CV: IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21 (WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes. Mol Cell Biol 2001, 21:1930–41. 10.1128/MCB.21.6.1930-1941.2001View ArticlePubMed CentralPubMedGoogle Scholar
  11. Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, et al.: NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol 1994, 153:712–23.PubMedGoogle Scholar
  12. Kunsch C, Rosen CA: NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 1993, 13:6137–46.PubMed CentralPubMedGoogle Scholar
  13. Bond M, Baker AH, Newby AC: Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochem Biophys Res Commun 1999, 264:561–7. 10.1006/bbrc.1999.1551View ArticlePubMedGoogle Scholar
  14. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827–39. 10.1161/01.RES.0000070112.80711.3DView ArticlePubMedGoogle Scholar
  15. Tanaka K, Hasegawa J, Asamitsu K, Okamoto T: Prevention of the ultraviolet B-mediated skin photoaging by a nuclear factor kappaB inhibitor, parthenolide. J Pharmacol Exp Ther 2005, 315:624–30. 10.1124/jpet.105.088674View ArticlePubMedGoogle Scholar
  16. Dasu MR, Barrow RE, Spies M, Herndon DN: Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblast. Burns 2003, 29:527–31. 10.1016/S0305-4179(03)00154-2View ArticlePubMedGoogle Scholar
  17. Nishida S, Kikuichi S, Yoshioka S, Tsubaki M, Fujii Y, Matsuda H, et al.: Induction of apoptosis in HL-60 cells treated with medicinal herbs. Am J Chin Med 2003, 31:551–62. 10.1142/S0192415X03001211View ArticlePubMedGoogle Scholar
  18. Yi P, Lu FE, Xu LJ, Chen G, Dong H, Wang KF: Berberine reverses free-fatty-acid-induced insulin resistance in 3 T3-L1 adipocytes through targeting IKKbeta. World J Gastroenterol 2008, 14:876–83. 10.3748/wjg.14.876View ArticlePubMed CentralPubMedGoogle Scholar
  19. Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, et al.: Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol 2008, 580:70–9. 10.1016/j.ejphar.2007.11.013View ArticlePubMedGoogle Scholar
  20. Resch M, Steigel A, Chen ZL, Bauer R: 5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea. J. Nat. Prod 1998, 61:347–50. 10.1021/np970430bView ArticlePubMedGoogle Scholar
  21. Auerbach BJ, Kiely JS, Cornicelli JA: A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem 1992, 201:375–80. 10.1016/0003-2697(92)90354-AView ArticlePubMedGoogle Scholar
  22. Fiddler GI, Lumley P: Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. Circulation 1990, 81:I69–178.PubMedGoogle Scholar
  23. Du CY, Choi RC, Zheng KY, Dong TT, Lau DT, Tsim KW: Yu Ping Feng San, an ancient Chinese herbal decoction containing Astragali Radix, Atractylodis Macrocephalae Rhizoma and Saposhnikoviae Radix, regulates the release of cytokines in murine macrophages. PLoS One 2013, 8:e78622. 10.1371/journal.pone.0078622View ArticlePubMed CentralPubMedGoogle Scholar
  24. Zhong XH, Zhou ZX, Li TS, Wang EQ, Shi WY, Chu SM: Anti-abortive effect of Radix scutellariae and Rhizoma atractylodis in mice. Am J Chin Med 2002, 30:109–17. 10.1142/S0192415X02000120View ArticlePubMedGoogle Scholar
  25. Boes S, Kim H: Evaluation of In Vitro Anti-Inflammatory Activities and Protective Effect of Fermented Preparations of Rhizoma Atractylodis Macrocephalae on Intestinal Barrier Function against Lipopolysaccharide Insult. Evid Based Complement Alternant Med 2013, 2013:363076.Google Scholar
  26. Liao J, Li PP, Wu CJ: Screening new photosensitizers from Chinese medicinal herbs and searching for herbal photodynamic killing effects on human stomach cancer cells. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997, 17:726–9.PubMedGoogle Scholar
  27. Xu Q, Yuan K, Lu J, Wang R, Wu F: A new strategy for regulating the immunological liver injury–effectiveness of DTH-inhibiting agents on DTH- induced liver injury to picryl chloride. Pharmacol Res 1997, 36:401–9. 10.1006/phrs.1997.0249View ArticlePubMedGoogle Scholar
  28. Kim HH, Shin CM, Park CH, Kim KH, Cho KH, Eun HC, et al.: Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. J Lipid Res 2005, 46:1712–20. 10.1194/jlr.M500105-JLR200View ArticlePubMedGoogle Scholar
  29. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, et al.: p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transacitivation mediated by tumor necrosis factor. J Biol Chem 1998, 273:3285–90. 10.1074/jbc.273.6.3285View ArticlePubMedGoogle Scholar
  30. Lu Y, Wahl LM: Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol 2005, 175:5423–9. 10.4049/jimmunol.175.8.5423View ArticlePubMedGoogle Scholar
  31. Kim EK, Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochem Biophys Acta 1802, 2010:396–405.Google Scholar
  32. Hong MJ, Ko EB, Park SK, Chang MS: Inhibitory effect of Astragalus membranaceus root on matrix metalloproteinase-1 collagenase expression and procollagen destruction in ultraviolet B-irradiated human dermal fibroblasts by suppressing nuclear factor kappa-B activity. J Pharm Pharmacol 2013, 65:142–8. 10.1111/j.2042-7158.2012.01570.xView ArticlePubMedGoogle Scholar
  33. Bond M, Chase AJ, Baker AH, Newby AC: Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 2001, 50:556–65. 10.1016/S0008-6363(01)00220-6View ArticlePubMedGoogle Scholar

Copyright

© Bae et al.; licensee BioMed Central. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.